Lívia Bitencourt Pascoal

7PUBLICATIONS
23CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 12, 2025
Resolvin D2 and Its Effects on the Intestinal Mucosa of Crohn's Disease Patients: A Promising Immune Modulation Therapeutic Target.

Livia Bitencourt Pascoal, Bruno Lima Rodrigues, Guilherme Augusto da Silva Nogueira

|Apr 28, 2025
Viral infections and immune modulation in bladder cancer: implications for immunotherapy.

Lívia Bitencourt Pascoal, Mehrsa Jalalizadeh, Gabriela Barbosa

|Feb 17, 2025
Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients.

Livia Moreira Genaro, Juliana Carron, Marina Moreira de Castro

|Feb 21, 2022
Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation.

Bruno Lima Rodrigues, Isabella Dotti, Lívia Bitencourt Pascoal

|Apr 18, 2019
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease.

Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal

Pageof 2